Associate Professor
Translational Science and Therapeutics, Fred Hutch
Facility Director, Therapeutic Products Program
Fred Hutch
Dr. Folashade Otegbeye is a clinical researcher who specializes in blood stem cell transplantation for blood cancers and other diseases of blood and marrow. In her lab, she studies the immunology of transplant and immune cell therapy for a variety of cancers. In her role as facility director of the Hutch’s Therapeutic Products shared resource, she works with the Hutch’s cellular immunotherapy labs to translate their research ideas into clinical products. Her research in the clinic is aimed at improving transplant care for people with bone marrow failure syndromes and myeloproliferative disorders, in which blood cells grow abnormally in the marrow.
Associate Professor
University of Washington School of Medicine
Hematology and Oncology Fellowship, University Hospitals Cleveland Medical Center; Case Western Reserve University, 2016
Internal Medicine Internship & Residency, Bridgeport Hospital Yale New Haven Health, 2013
MPH, Harvard School of Public Health, 2009
MBChB, Obafemi Awolowo University Ile-Ife, 2005
Natural killer cells and other immune effector cell therapy
Post-transplant immune reconstitution
Haploidentical and cord blood transplantation
Immune effector cell therapy
Hematopoietic cell transplantation for bone marrow failure syndromes
Hematopoietic cell transplantation for myelofibrosis
Acute myeloid leukemia and myelodysplastic syndrome
Acute lymphoblastic leukemia
— Dr. Folashade Otegbeye
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email media@fredhutch.org or call 206.667.2210